ProShares Ultra Nasdaq Biotechnology (BIB)

Currency in USD
50.08
-0.15(-0.30%)
Closed·
After Hours
50.080.00(0.00%)
·
Day's Range
49.2450.09
52 wk Range
33.7869.17

Key Statistics

Morning Star Rating
-
Risk Rating
-
Bid / Ask
-
Prev. Close
50.08
Price Open
50.07
Volume
12,115
Average Vol. (3m)
8,692
1-Year Change
-18.90%
Day’s Range
49.24-50.09
52-Week Range
33.78-69.17
Market Cap
19.71B
Expense Ratio
0.95%
How do you feel today about BIB?
Vote to see community's results!
or

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Performance

Name
YTD
3M
1Y
3Y
5Y
10Y
Growth of 10001,0051,068769992741537
Fund Return+0.46%+6.81%-23.08%-0.27%-5.82%-6.03%

United States Treasury Bills 0%

-7.75%--4,000,000
VRTX5.17%375.63-2.60%5,764
AMGN5.09%284.70+0.01%8,843
GILD5.08%110.280.00%23,149
REGN4.20%559.80+0.84%3,874
ALNY3.26%435.10+1.63%4,183
AZN3.12%74.57+1.32%21,754
ARGX1.52%672.35-0.12%1,162
SMMT1.44%28.070-1.58%27,353
INSM1.41%109.30-1.76%6,708

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq Biotechnology Index, by using full replication technique. ProShares Trust - ProShares Ultra Nasdaq Biotechnology was formed on April 7, 2010 and is domiciled in the United States.

Industry
-
Sector
-
0
Equity Type
ETF

FAQ

How is the performance of BIB?

As of 08 Aug 2025, BIB is trading at a price of 50.08, with a previous close of 50.08. The stock has fluctuated within a day range of 49.24 to 50.09, while its 52-week range spans from 33.78 to 69.17.

What is the current price of BIB?

The BIB stock price today is 50.08.

Does BIB Pay Dividends? What’s The Current Dividend Yield?

The ProShares Ultra Nasdaq Biotechnology dividend yield is 1.36%.

What is the ticker symbol for ProShares Ultra Nasdaq Biotechnology?

The ticker symbol for ProShares Ultra Nasdaq Biotechnology is BIB.

What is the BIB premarket price?

BIB's last pre-market stock price is 50.08.

What is the BIB after hours price?

BIB's last after hours stock price is 50.08.

What is the P/E ratio of BIB?

The P/E ratio for BIB is 15.88.

What is BIB?

BIB is an ETF issued by ProShares and is listed and traded on the NASDAQ

From a Technical Analysis Perspective, Is BIB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

What is the BIB market cap?

The market cap for BIB is 50.59M.

When is the BIB dividend date?

The next dividend date for BIB is 24 Jun 2025.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.